Clinical Trial Update: Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial in prostate cancer assesses the correlation between SUV measurements on 18F-DCFPyL PET/CT and Gleason score; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pylarify (piflufolastat F-18)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED